Breaking News Instant updates and real-time market news.

CBS

CBS

$52.87

-0.28 (-0.53%)

07:31
08/07/18
08/07
07:31
08/07/18
07:31

CBS downgraded to Hold from Buy at Argus

  • 09

    Aug

  • 06

    Sep

  • 27

    Sep

CBS CBS
$52.87

-0.28 (-0.53%)

08/06/18
LOOP
08/06/18
NO CHANGE
Target $33
LOOP
Hold
Viacom affiliate revenue to come down, says Loop Capital
Loop Capital analyst Alan Gould kept his Hold rating and $33 price target on Viacom (VIAB) ahead of its Q3 results but lowered his EPS estimate by 5c to $1.05 and his FY19 EPS view to $4.50 from $4.75. The analyst cites a more cautious outlook on future affiliate negotiations and a reduced TV revenue with no major affiliate renewal deals expected until the second half of 2019. Though Gould notes that valuation on the stock is inexpensive, he also expects any potential CBS (CBS) tie-up not to yield a premium paid by either side.
08/03/18
BNCH
08/03/18
NO CHANGE
Target $90
BNCH
Buy
CBS has 'plenty' of intrinsic value despite legal trouble, says Benchmark
Benchmark analyst Daniel Kurnos acknowledges that CBS shares are "difficult to buy" ahead of a resolution of the impending legal challenges at both the executive and board levels, but he also sees "plenty" of intrinsic fundamental value. The company reported solid fundamental results again while also accelerating its 8M All Access subscriber forecast by a year and establishing a 16M sub forecast for its OTT service by 2022, said Kurnos. The analyst, who also noted that over 60% of revenue now comes from non-advertising sources, has a Buy rating and $90 price target on CBS shares.
08/03/18
JPMS
08/03/18
NO CHANGE
Target $75
JPMS
Overweight
CBS fundamentals are 'clearly not the issue,' says JPMorgan
Fundamentals are "clearly not the issue" for CBS (CBS) shares as the company continues to deliver or exceed expectations on comp growth, content sales, and over-the-top offerings, JPMorgan analyst Alexia Quadrani tells investors in a post-earnings research note titled "Another Beat and Favorable Outlook But That is Not the Near-Term Story." Unfortunately, the near term focus will remain on potential management changes, a court battle to determine who really controls the strategic direction of the company and how well CBS is positioned longer-term as a standalone or combined with Viacom (VIAB), the analyst adds. As such, the analyst sees CBS shares as range-bound in the near-term. However, over the longer-term, Quadrani believes "it is hard to ignore the obvious disconnect between valuation and the ongoing healthy earnings growth profile for the next few years." She reiterates an Overweight rating on CBS with a $75 price target.
07/31/18
07/31/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CBS (CBS) downgraded to Market Perform from Outperform at Cowen with analyst Doug Creutz saying the combination of the legal fight with National Amusements, the potential for a recombination with Viacom (VIAB) and the allegations of sexual harassment against CEO Les Moonves create "too many unquantifiable variables." 2. Caterpillar (CAT) downgraded to Equal Weight from Overweight at Barclays with analyst Adam Seiden saying the company's largest end-markets are no longer at trough. Further, he believes Caterpillar's second half of 2018 price initiatives, directed towards offsetting supply chain and materials cost increases, will limit its ability to expand margins. 3. WisdomTree (WETF) downgraded to Sell from Neutral at Citi with analyst William Katz saying he believes WisdomTree's price-to-earnings multiple can further contract amid mixed flow dynamics and flat earnings growth prospects out to 2020. 4. Adient (ADNT) downgraded to Underweight from Equal Weight at Morgan Stanley. 5. Tupperware Brands (TUP) downgraded to Sell from Hold at Argus with analyst Deborah Ciervo citing the company's disappointing Q2 revenue and reduced outlook for FY18. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

WASH

Washington Trust

$50.47

0.18 (0.36%)

07:59
06/26/19
06/26
07:59
06/26/19
07:59
Initiation
Washington Trust initiated  »

Washington Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

07:59
06/26/19
06/26
07:59
06/26/19
07:59
Upgrade
Micron rating change  »

Micron upgraded to Buy at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

CRCM

Care.com

$14.13

0.21 (1.51%)

, BBY

Best Buy

$66.42

-1.02 (-1.51%)

07:58
06/26/19
06/26
07:58
06/26/19
07:58
Downgrade
Care.com, Best Buy rating change  »

Care.com downgraded to…

CRCM

Care.com

$14.13

0.21 (1.51%)

BBY

Best Buy

$66.42

-1.02 (-1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Downgrade
Kinder Morgan rating change  »

Kinder Morgan downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEP

Holly Energy Partners

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Downgrade
Holly Energy Partners rating change  »

Holly Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

GEL

Genesis Energy

$21.59

-0.38 (-1.73%)

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Downgrade
Genesis Energy rating change  »

Genesis Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$26.80

-0.36 (-1.33%)

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Upgrade
Williams rating change  »

Williams upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRN

Acceleron

$39.60

-0.49 (-1.22%)

07:52
06/26/19
06/26
07:52
06/26/19
07:52
Hot Stocks
Acceleron completes target enrollment in PULSAR Phase 2 trial of sotatercept »

Acceleron Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 04

    Apr

KSHB

KushCo Holdings

$0.00

(0.00%)

07:52
06/26/19
06/26
07:52
06/26/19
07:52
Initiation
KushCo Holdings initiated  »

Benchmark starts KushCo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

AYX

Alteryx

$104.20

-2 (-1.88%)

07:52
06/26/19
06/26
07:52
06/26/19
07:52
Recommendations
Alteryx analyst commentary  »

Alteryx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSN

Parsons

$36.77

-0.045 (-0.12%)

07:51
06/26/19
06/26
07:51
06/26/19
07:51
Downgrade
Parsons rating change  »

Parsons downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$37.51

-0.625 (-1.64%)

07:48
06/26/19
06/26
07:48
06/26/19
07:48
Upgrade
Energizer rating change  »

Energizer upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$156.00

-4.88 (-3.03%)

, WMT

Walmart

$110.72

-0.53 (-0.48%)

07:48
06/26/19
06/26
07:48
06/26/19
07:48
Recommendations
FedEx, Walmart, Target, Amazon.com analyst commentary  »

FedEx price target…

FDX

FedEx

$156.00

-4.88 (-3.03%)

WMT

Walmart

$110.72

-0.53 (-0.48%)

TGT

Target

$85.70

-1.03 (-1.19%)

AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 30

    Jul

  • 31

    Jul

  • 15

    Aug

  • 21

    Aug

  • 17

    Sep

  • 13

    Nov

07:45
06/26/19
06/26
07:45
06/26/19
07:45
General news
U.S. MBA reported mortgage applications bounced 1.3% »

U.S. MBA reported…

UPWK

Upwork

$15.07

-0.41 (-2.65%)

, FVRR

Fiverr

$29.00

-0.2 (-0.68%)

07:44
06/26/19
06/26
07:44
06/26/19
07:44
Upgrade
Upwork, Fiverr rating change  »

Upwork upgraded to Buy…

UPWK

Upwork

$15.07

-0.41 (-2.65%)

FVRR

Fiverr

$29.00

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LINX

Linx S.A.

$0.00

(0.00%)

07:41
06/26/19
06/26
07:41
06/26/19
07:41
Syndicate
Linx S.A. 32.8M share IPO priced at $9.40 »

We are told the official…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

07:40
06/26/19
06/26
07:40
06/26/19
07:40
General news
Treasury Market Outlook: Treasury yields jumped higher »

Treasury Market Outlook:…

BBRX

Braeburn Pharmaceuticals

$0.00

(0.00%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Initiation
Braeburn Pharmaceuticals initiated  »

Braeburn Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

$90.27

-0.53 (-0.58%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Upgrade
Fiserv rating change at Northcoast »

Fiserv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVSI

Envision Solar

$5.11

-0.22 (-4.13%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Initiation
Envision Solar initiated at Maxim »

Envision Solar initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$1.66

-0.05 (-2.93%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Initiation
Kadmon initiated  »

Oppenheimer bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$57.44

-0.58 (-1.00%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Hot Stocks
Novocure announces publication of IQWiG rapid report for Optune »

Novocure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTR

CapStar Financial

$15.01

0.05 (0.33%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Downgrade
CapStar Financial rating change at Sandler ONeill »

CapStar Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCRX

Pacira

$43.53

0.39 (0.90%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Hot Stocks
Pacira says results show EXPAREL associated with 'significantly less' opioid use »

Pacira BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODT

Odonate Therapeutics

$28.14

-0.29 (-1.02%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Syndicate
Odonate Therapeutics 4.75M share Spot Secondary priced at $26.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.